Search results
Found 62 matches for
Oxford surgeons have devised a course to train healthcare providers in Africa to effectively treat children with clubfoot in under resourced situations.
New research highlights colorectal cancer trends and survival rates
16 April 2025
A recent study published in the American Journal of Gastroenterology investigates the incidence and survival rates of colorectal cancer (CRC) in the UK. The research offers healthcare decision-makers crucial insights for planning, management and screening for colorectal cancer.
Global study supports the immunity debt hypothesis for flu after Covid restrictions
7 April 2025
A new NDORMS study supports the hypothesis of immunity debt showing increases of influenza rates one year after global relaxation of COVID-19 restrictions. It highlights the need for proactive preparations in future pandemic response strategies.
NDORMS study highlights lingering symptoms long after COVID-19 infection
15 November 2024
A new international study has shed light on the significant burden of post-acute COVID-19 symptoms across N. America, Europe and Asia.
Post-acute infection syndrome is not unique to COVID-19
25 October 2024
Patients hospitalised with COVID-19 often report a wide range of symptoms months after their initial illness. But a new study from NDORMS shows that post-acute infection syndrome (PAIS) is not unique to COVID-19 and can also occur after other respiratory infections.
Healthy lifestyle lowers the risk of post-COVID complications
13 August 2024
A new NDORMS study has found that a healthy lifestyle can significantly reduce the risk of post-COVID complications, hospitalisation, and death.
New real-world evidence network co-ordination centre for the UK
17 June 2024
Daniel Prieto-Alhambra from NDORMS is to lead a new co-ordination centre for a pilot real-world evidence network to utilise data gathered from multiple UK sources.
Cracking the genetic code for COVID-19 vaccine effectiveness
21 May 2024
Researchers have unveiled critical insights into how our genetic makeup influences the body's response to COVID-19 vaccines. The study, published in Nature Communications, may open new paths to personalised vaccination strategies.
COVID-19 vaccines effectiveness: results from Norway demonstrate the reproducibility of federated analytics
11 April 2024
Researchers from NDORMS and the University of Oslo, have successfully replicated findings from recently published international studies on the effectiveness of COVID-19 vaccines to prevent long COVID and post-acute complications.
New study reveals long-term mental health risks after COVID-19
21 March 2024
A new study published in Nature Human Behaviour sheds light on the long-term mental health consequences of COVID-19 infection and the growing evidence of the protective effect of vaccination on reducing the risk.
COVID jab linked to lower risk of COVID-19-related clot and heart complications
13 March 2024
NDORMS research shows that vaccination reduced the risk of heart failure and some clot-related complications for up to a year.
Removing bias from healthcare AI tools
22 February 2024
Rapid advances in Artificial Intelligence (AI) have opened the way for the creation of a huge range of new healthcare tools, but to ensure that these tools do not exacerbate preexisting health inequities, researchers urge the use of more representative data in their development.
COVID-19 vaccines found effective in reducing long COVID symptoms
12 January 2024
A recent study has revealed the effectiveness of COVID-19 vaccines in preventing long COVID.
DARWIN EU® success leads to expansion
3 May 2023
The European Medicines Agency (EMA) initiative DARWIN EU® has completed its first studies and is calling for new data partners
Data-Driven research will map COVID-19 vaccine effectiveness in Brazil and Pakistan
5 April 2023
A study to monitor the safety and effectiveness of the COVID-19 vaccine in the Global South, has received funding from the Bill & Melinda Gates Foundation’s Grand Challenges initiative.
Jonathan Cook elected as Society for Clinical Trials board member
3 April 2023
Associate Professor Jonathan Cook has been elected to the Society for Clinical Trials (SCT) board.
NIHR Fellowships awarded to NDORMS researchers
17 March 2023
Congratulations to Eileen Morrow and Mae Chester-Jones who have received NIHR Doctoral Fellowships
OCTRU - delivering answers to important clinical questions
7 March 2023
The Oxford Clinical Trials Research Unit (OCTRU) has received NIHR benchmarking results and offers excellent value for money according to the report
New cost-benefit model of Fracture Liaison Services helping healthcare decision makers
9 February 2023
The newly developed model to estimate the health benefits and budget impact of Fracture Liaison Services (FLS) finds them highly effective in shaping positive patient outcomes, and will help drive policy decisions.
Study reveals new evidence on rare blood-clotting condition after covid-19 vaccination
28 October 2022
Researchers from NDORMS at the University of Oxford have investigated claims that some adenovirus-based COVID-19 vaccines increase the risk of rare blood clots compared to their mRNA-based counterparts.
Higher risk of blood clots in COVID-19 outpatients, largely reduced after vaccination
19 August 2022
Researchers at NDORMS have studied the association between ambulatory COVID-19 and short-term risk of venal thrombosis and the clinical and genetic risk factors predisposing them to developing post–COVID-19 thrombosis.